Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience

Sorafenib is a multi-targeted tyrosine kinase receptor inhibitor used to treat patients with advanced gastrointestinal stromal tumors (GISTs). The present study evaluated the efficacy and tolerability of sorafenib therapy for patients with GISTs. Between January 2001 and November 2012, 25 patients,...

Descripción completa

Detalles Bibliográficos
Autores principales: KEFELI, UMUT, BENEKLI, MUSTAFA, SEVINC, ALPER, YILDIZ, RAMAZAN, KAPLAN, MUHAMMED ALI, CILTAS, AYDIN, BALAKAN, OZAN, ISIKDOGAN, ABDURRAHMAN, COSKUN, UGUR, DANE, FAYSAL, HARPUTLUOGLU, HAKAN, KARACA, HALIT, YAZILITAS, DOGAN, DURNALI, AYSE, KAYA, ALI OSMAN, DEMIRCI, UMUT, GUMUS, MAHMUT, BUYUKBERBER, SULEYMAN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789037/
https://www.ncbi.nlm.nih.gov/pubmed/24137379
http://dx.doi.org/10.3892/ol.2013.1408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789037/
https://www.ncbi.nlm.nih.gov/pubmed/24137379
http://dx.doi.org/10.3892/ol.2013.1408

Ejemplares similares